Genetics - Recording a family history
Dr John Spicer and Dr Imran Rafi explain how to create a genetic map. Read more
The study showed RA patients taking the tumour necrosis factor (TNF)-alpha blocker infliximab had an increased atherogenic index and higher level of total cholesterol a year after treatment was initiated.
TNF-alpha blockers may add to the increased cardiovascular risk RA patients are known to have. Cardiovascular disease is more common in RA patients than the general population.
Under NICE guidance, RA patients are offered infliximab or the TNF-alpha blocker etanercept in combination with methotrexate if they have failed to respond to two other disease modifying anti-rheumatic drugs including methotrexate.
For the study, plasma lipoprotein concentrations were assessed in 55 RA patients and 55 controls, showing no differences between the groups' lipid profiles.
RA patients had a disease activity score above 3.2 and were starting therapy with infliximab.
At one year, 31 RA patients were reassessed for lipid profile. HDL cholesterol levels were similar to those at baseline and the atherogenic index was 4 per cent higher than baseline. Total cholesterol had increased from 5.55 mmol/l to 6.01 mmol/l.
Arch Rheum Dis 2007 Online
What do you think? Comment below or email us at healthcare.republic@haymarket.com
Quick search - use * for an abbreviated search, eg nico*
Dr John Spicer and Dr Imran Rafi explain how to create a genetic map. Read more
An apology and sympathy can go a long way to resolving a grievance, explains the MDDUS's medico-lega... Read more
Play out the doctor, patient and assessor roles in a study group or plan on your own how you would a... Read more
Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more
Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more
Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more
Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more
Comments
Only registered users may comment. Log in now or register for a free account.
There are problems with your form submission.
Please review the errors shown below.